Fingerprint
Dive into the research topics of 'Prognostic factorsofsurvival inarandomizedphaseIIItrial (MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically